Sino Biopharmaceutical Limited (SBHMY) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ACXP, ALRN, ANEB, CNTA, CYT and others.
SBHMY has a market capitalization of $14.2B, compared to an average peer market cap of $589.33M. SBHMY is significantly larger than its average peer.
